Delivery Order SPE2DB22D3301-SPE2DB26FX3JU
- Not listed
- The Defense Logistics Agency awarded a $27,768.05 delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 count) on October 16, 2025, with an ultimate completion date of October 17, 2025. The contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Citalopram HBr 40 mg tablets in quantities of 500 units, with a ceiling value of $6,023.38. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by September 3, 2025, and will be performed at the contractor's corporate office location in...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Citalopram HBR 20 mg tablets (500 count) with a ceiling value of $16,986.60. This firm fixed-price delivery order, with an ultimate completion date of September 2, 2025, represents a competitively awarded, non-set-aside contract executed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Citalopram HBR 20 mg tablets in quantities of 500 units. This firm fixed-price delivery order carries a ceiling value of $34,632.46 and is scheduled for completion by September 19, 2025. The contract was awarded competitively without set-aside designation to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 10 mg tablets (500 count) valued at $46,580.81 under a firm fixed-price contract. This competitively awarded delivery order, with no set-aside designation, was issued on September 23, 2025, with an ultimate completion date of September 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,023.19 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 tablets) on September 8, 2025, with an ultimate completion date of September 9, 2025. This contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $6,948.25 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Citalopram HBr 20 mg tablets (500 count). This competitive award utilizes firm fixed pricing with a completion date of September 8, 2025, and represents a non-set-aside procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $27,356.67 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets in quantities of 500 units. This firm fixed-price, competitively awarded delivery order was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Citalopram HBr 10 mg tablets (500 count) with a ceiling value of $10,708.82. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Citalopram HBr 20 mg tablets in quantities of 500 units, with a ceiling value of $61,596.66 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3JUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 count) on October 16, 2025, with a ceiling value of $6,927.78 and an ultimate completion date of October 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitively awarded contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which is the headquarters location of AmerisourceBergen Drug Corp. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 10/16/25 |